EA199900102A1 - Таблетка малеата тримебутина, покрытая оболочкой - Google Patents

Таблетка малеата тримебутина, покрытая оболочкой

Info

Publication number
EA199900102A1
EA199900102A1 EA199900102A EA199900102A EA199900102A1 EA 199900102 A1 EA199900102 A1 EA 199900102A1 EA 199900102 A EA199900102 A EA 199900102A EA 199900102 A EA199900102 A EA 199900102A EA 199900102 A1 EA199900102 A1 EA 199900102A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tablet
shell
trimebutin
maleat
covered
Prior art date
Application number
EA199900102A
Other languages
English (en)
Other versions
EA001506B1 (ru
Inventor
Лутфи Бенкеррур
Бернар Доа
Original Assignee
Парк-Давиз
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199900102(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Парк-Давиз filed Critical Парк-Давиз
Publication of EA199900102A1 publication Critical patent/EA199900102A1/ru
Publication of EA001506B1 publication Critical patent/EA001506B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Abstract

Таблетка малеата тримебутина, покрытая оболочкой, предназначенная для перорального приема, отличающаяся тем, что она состоит: из ядра-продукта, в состав которого входят от 30 до 60% малеата тримебутина и инертные компоненты, предназначенные для приготовления вышеназванного ядра-продукта, и компоненты, предназначенные для стойкости и освобождения активного вещества, водорастворимой оболочки временного действия, но достаточной для предупреждения разложения ядра-продукта и преждевременного освобождения активного вещества в полости рта.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900102A 1996-08-07 1997-07-11 Таблетка малеата тримебутина, покрытая оболочкой EA001506B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609956A FR2752162B1 (fr) 1996-08-07 1996-08-07 Comprime de maleate de trimebutine pellicule
PCT/FR1997/001281 WO1998005320A1 (fr) 1996-08-07 1997-07-11 Comprime de maleate de trimebutine pellicule

Publications (2)

Publication Number Publication Date
EA199900102A1 true EA199900102A1 (ru) 1999-06-24
EA001506B1 EA001506B1 (ru) 2001-04-23

Family

ID=9494890

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900102A EA001506B1 (ru) 1996-08-07 1997-07-11 Таблетка малеата тримебутина, покрытая оболочкой

Country Status (27)

Country Link
EP (1) EP0942718B1 (ru)
JP (1) JP2000515535A (ru)
KR (1) KR100539642B1 (ru)
CN (1) CN1206986C (ru)
AR (1) AR008820A1 (ru)
AT (1) ATE300297T1 (ru)
AU (1) AU3697097A (ru)
BR (1) BR9711032B1 (ru)
CA (1) CA2256751C (ru)
CO (1) CO4900042A1 (ru)
CZ (1) CZ294195B6 (ru)
DZ (1) DZ2272A1 (ru)
EA (1) EA001506B1 (ru)
ES (2) ES2244002T3 (ru)
FR (1) FR2752162B1 (ru)
GR (1) GR1002907B (ru)
HK (1) HK1020888A1 (ru)
HU (1) HU228040B1 (ru)
IT (1) IT1294671B1 (ru)
MX (2) MXPA98010007A (ru)
OA (1) OA10968A (ru)
PL (1) PL188839B1 (ru)
PT (2) PT942718E (ru)
TN (1) TNSN97134A1 (ru)
TR (1) TR199900261T2 (ru)
UA (1) UA52682C2 (ru)
WO (1) WO1998005320A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
FR2834889B1 (fr) 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
EP1726621A1 (en) * 2005-05-26 2006-11-29 Cytec Surface Specialties, S.A. Thermosetting powder compositions
CN100393311C (zh) * 2006-01-26 2008-06-11 孙伟丰 马来酸曲美布汀分散片
CN1927185B (zh) * 2006-10-19 2010-05-19 开开援生制药股份有限公司 具速释部分的马来酸曲美布汀缓释片及其制备工艺
CA2936400C (en) 2008-07-28 2018-03-27 Takeda Pharmaceutical Company Limited Pharmaceutical composition
KR101048487B1 (ko) * 2008-08-19 2011-07-11 한국콜마 주식회사 말레인산트리메부틴 서방정
KR101220829B1 (ko) * 2010-07-16 2013-01-10 안국약품 주식회사 트리메부틴 함유 서방성 정제
CN102462657A (zh) * 2010-11-15 2012-05-23 杭州赛利药物研究所有限公司 马来酸曲美布汀栓剂及其制备方法
JP6341196B2 (ja) * 2013-03-21 2018-06-13 大正製薬株式会社 固形製剤
RU2536254C1 (ru) * 2013-11-26 2014-12-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Таблетки-ретард с тримебутином
CA2973944C (en) * 2015-01-26 2019-07-30 Daiichi Sankyo Company, Limited Solid composition of pyrrole carboxamide
RU2706166C2 (ru) * 2017-11-20 2019-11-14 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770301C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770300C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
CN113171353B (zh) * 2021-04-25 2022-10-21 海南普利制药股份有限公司 一种马来酸曲美布汀片

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045845B2 (ja) * 1979-10-31 1985-10-12 田辺製薬株式会社 医薬物質含有マイクロカプセルの製法
JPS57197214A (en) * 1981-05-29 1982-12-03 Tanabe Seiyaku Co Ltd Rapid-releasing microcapsule and its preparation
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5916821A (ja) * 1982-07-16 1984-01-28 Tanabe Seiyaku Co Ltd 非凝集性マイクロカプセルの製法
FR2640876B1 (ru) * 1988-12-28 1993-09-24 Jouveinal Sa
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JP2836493B2 (ja) * 1994-08-04 1998-12-14 田辺製薬株式会社 苦味隠蔽されたマレイン酸トリメブチン含有製剤

Also Published As

Publication number Publication date
AR008820A1 (es) 2000-02-23
ATE300297T1 (de) 2005-08-15
CN1206986C (zh) 2005-06-22
CN1226162A (zh) 1999-08-18
DZ2272A1 (fr) 2004-06-20
ES2130081B1 (es) 2000-01-01
EP0942718A1 (fr) 1999-09-22
KR20000029866A (ko) 2000-05-25
PT942718E (pt) 2005-10-31
CZ37699A3 (cs) 1999-05-12
HK1020888A1 (en) 2000-05-26
WO1998005320A1 (fr) 1998-02-12
TNSN97134A1 (fr) 2005-03-15
KR100539642B1 (ko) 2005-12-29
UA52682C2 (ru) 2003-01-15
IT1294671B1 (it) 1999-04-12
CA2256751C (en) 2008-09-23
BR9711032B1 (pt) 2008-11-18
ITGE970067A1 (it) 1999-02-06
ES2130081A1 (es) 1999-06-16
TR199900261T2 (xx) 1999-04-21
CA2256751A1 (fr) 1998-02-12
PL188839B1 (pl) 2005-05-31
MXPA98010007A (es) 2002-07-22
GR1002907B (el) 1998-05-13
PT102031B (pt) 2004-07-30
EA001506B1 (ru) 2001-04-23
BR9711032A (pt) 1999-08-17
EP0942718B1 (fr) 2005-07-27
PL331517A1 (en) 1999-07-19
JP2000515535A (ja) 2000-11-21
CZ294195B6 (cs) 2004-10-13
FR2752162B1 (fr) 1998-11-06
HU228040B1 (en) 2012-09-28
HUP9902878A3 (en) 2000-11-28
HUP9902878A2 (hu) 2000-04-28
ES2244002T3 (es) 2005-12-01
PT102031A (pt) 1998-02-27
AU3697097A (en) 1998-02-25
FR2752162A1 (fr) 1998-02-13
CO4900042A1 (es) 2000-03-27
OA10968A (fr) 2001-10-30
MX9706053A (es) 1998-02-28

Similar Documents

Publication Publication Date Title
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
AU6136199A (en) Dosage form comprising therapeutic formulation
ZA200205512B (en) Novel substituted benzimidazole dosage forms and methods of using same.
BE2011C013I2 (ru)
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
AU1227899A (en) Osmotic medicament releasing system
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
ZA200000169B (en) Process for the preparation of pellets with a content of up to 90 wt.% of a pharmaceutical active ingredient.
DK1007006T3 (da) Formulering af cefadroxilmonohydrattablet
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
NO975634L (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
HK15695A (en) Solid oral administration forms containing ifosfamide as active agent
EP0285871A3 (en) Sustained release granulate without binding agent
NO975680D0 (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
HUT48096A (en) Insecticides comprising 2-imino-1,3-dithiethane derivatives as active ingredient and process for producing the active ingredients
ZA975755B (en) Useful formulations of acid addition salt drugs.
HUT46323A (en) Compositions against pestiferous insects and process for producing compositions against zooparasites and comprising milbemycin derivatives as active ingredient and for producing the active ingredients
SE9902742D0 (sv) New pharmaceutical formultion
HUP9903880A3 (en) Naphtoquinone-derivatives, process for their preparation, fungicidal, insecticidal and acaricidal compositions, containing them as active ingredient and process for their use
HUT48606A (en) Fungicides comprising hydroxyalkyltriazolyl derivatives as active ingredient and process for producing the active ingredients

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ

MK4A Patent expired

Designated state(s): RU